News

SurvivorNet on MSN2d
CAR T-Cell Therapy, Liso-Cel, Achieves Superior Outcomes For Patients With Hard-To-Treat Large B-Cell Lymphoma
Liso-Cel is a type of CAR T-cell therapy — a revolutionary approach that uses a patient's own immune cells to fight cancer.
CURE3d
First Patient with CD5-Positive T-Cell Lymphoma Dosed with MB-105
The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.
Medical Dialogues2d
NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma: Study
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
Genomic analysis provides insight into underpinnings of new treatment combination for deadly, Asian-prevalent lymphoma
A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...
CURE3d
Odronextamab Elicits Responses in Some With Lymphoma Following CAR-T
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
Cutting-edge cancer treatment isn't known by most Americans
The answer turned out to be a cutting-edge treatment that few Americans know about, according to Roswell Park Comprehensive ...
News-Medical.Net on MSN1d
Novel cancer immunotherapy approachcould complement existing CAR-T treatments
Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.